Stem Cell Biology and Regenerative Medicine

Funding

In addition to its generous endowment, the Institute for Stem Cell Biology and Regenerative Medicine at Einstein is supported by external sources, including the NIH and the New York State Empire State Stem Cell (NYSTEM) Board. Created in 2007, NYSTEM provided substantial funding support for stem cell research over the next decade. Notably, Einstein is among the highest-ranked institutions in New York competing for state support and, to date, Einstein has received thus far from NYSTEM over $24M in funding for stem cell research ranking 4th in total funding among all New York Institutions.

Funding from NYSTEM supported the creation of the Einstein Comprehensive Pluripotent Stem Cell Center, which consisted of three units: the Human Pluripotent Stem Cell Unit, the Cell-Sorting and Xenotransplantation Unit, and the Stem Cell Genomic Unit. In April 2014, the Stem Cell Institute was once again awarded $3,557,019 from NYSTEM to support the newly expanded Einstein Shared Facilities for Stem Cell Research which continues the services of the Human Pluripotent Stem Cell Unit, further enhances the Stem Cell Isolation and Xenotransplantation Core and supports the newly created Single-Cell Genomics Core. The members of the Institute are among the top funded Investigators at the Albert Einstein College of Medicine. Currently Stem Cell Investigators are PIs on awards that total approximately $21 million, of which $17M is federal, and $2M is foundation and $1.9M is NY State.

Einstein Benefactors

The endowment for the Institute comes in large part from longtime Einstein benefactors Ruth L. and David S. Gottesman.

Prior to joining the Einstein Board of Overseers in 2002, Dr. Ruth Gottesman had a distinguished 33-year academic career at the medical school. In 1968, she joined Einstein’s Children’s Evaluation and Rehabilitation Center (CERC) to develop a program for children with dyslexia and other learning disabilities. She went on to serve as CERC’s director of psychoeducational services and later as director of the adult literacy program. In 1999, she became founding director of the Fisher Landau Center for the Treatment of Learning Disabilities, a new division of CERC that was established to provide interdisciplinary services to individuals of all ages with learning disabilities.

David Gottesman is the founder and senior managing director of the First Manhattan Company, an investment advisory firm. He was chairman of the Board of Yeshiva University from 1990 to 1998.